Showing 3 posts of 18 posts found.

Pfizer Xalkori

US rivals Pfizer and Merck team up for lung cancer

August 27, 2014
Medical Communications, Research and Development, Sales and Marketing Merck, NSCLC, Roche, Xalkori, melanoma, pembrolizumab

The two biggest rival US pharma firms have joined forces to help develop a new combination treatment for certain non-small …

Merck logo

Merck and Advaxis team up on immuno-oncology

August 26, 2014
Manufacturing and Production, Medical Communications, Research and Development ASCO, Merck, immunology, pd-1, pembrolizumab

Advaxis and Merck have signed a research deal to investigational Merck’s PD-1 inhibitor pembrolizumab in combination with Advaxis’ listeria-based cancer …

Merck image

PD-1 cancer race heats up as Merck takes lead

July 2, 2014
Research and Development, Sales and Marketing ASCO, Cancer, Merck, melanoma, mk3475, oncology, pembrolizumab

Merck’s oncology drug pembrolizumab has taken a big step towards becoming Europe’s first PD-1 cancer treatment as the EMA accepts …

Latest content